Béres: HUF 20.3 bln in sales last year
According to the summary report of Béres Gyógyszergyár Zrt., in 2021, the company achieved a net sales revenue of HUF 20.3 billion, following sales of HUF 20.1 bln a year earlier, writes business daily Világgazdaság.
The income broke down to HUF 15.3 bln in domestic sales and HUF 5 bln of export sales.
Last year, it generated an after-tax profit of HUF 3.67 bln, down from HUF 4.7 bln in 2020.
The pharmaceutical company employed 561 people in 2021, up from 480 a year earlier.
According to the resolution of the general meeting, the company decided to pay a dividend of HUF 700 million.
ÁKK Sells HUF 82.5 bln of Bonds at Auction, Above Plan
EC Puts Hungary 2024 GDP Growth at 2.4%
HU-rizon Program: HUF 8 bln Funding for International Resear...
Marcelito Pomoy to Perform in Budapest Next Week
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
